CMIC：2020年早期药物开发报告（英文版）

While pivotal clinical trials remain critical to securing the approvalsrequired for the launch of new drugs, it is interesting and also encouraging to observe acommon thread running through some recent regulatory and policy discussions.

That theme is ever closer cooperation between industry sponsors and regulatoryauthorities, particularly in relation to new forms of therapy.

This e-book takes a look at some of the considerations when planning and conductingearly stage trials, high